These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30292735)

  • 61. Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson's Disease.
    Dumitrescu L; Marta D; Dănău A; Lefter A; Tulbă D; Cozma L; Manole E; Gherghiceanu M; Ceafalan LC; Popescu BO
    Front Neurosci; 2021; 15():689723. PubMed ID: 34220443
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson's Disease.
    Drobny A; Ngo PA; Neurath MF; Zunke F; López-Posadas R
    Front Med (Lausanne); 2021; 8():655123. PubMed ID: 34368179
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.
    Fang X
    Int J Neurosci; 2016 Sep; 126(9):771-6. PubMed ID: 26381230
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Positive effect of an electrolyzed reduced water on gut permeability, fecal microbiota and liver in an animal model of Parkinson's disease.
    Bordoni L; Gabbianelli R; Fedeli D; Fiorini D; Bergheim I; Jin CJ; Marinelli L; Di Stefano A; Nasuti C
    PLoS One; 2019; 14(10):e0223238. PubMed ID: 31600256
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Parkinson's disease pathogenesis, evolution and alternative pathways: A review.
    Alexoudi A; Alexoudi I; Gatzonis S
    Rev Neurol (Paris); 2018 Dec; 174(10):699-704. PubMed ID: 30131173
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetic and Environmental Considerations for Inflammatory Bowel Disease.
    Kuhnen A
    Surg Clin North Am; 2019 Dec; 99(6):1197-1207. PubMed ID: 31676058
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson's Disease.
    Mulak A; Koszewicz M; Panek-Jeziorna M; Koziorowska-Gawron E; Budrewicz S
    Front Neurosci; 2019; 13():992. PubMed ID: 31611762
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inflammatory Bowel Disease and Parkinson's Disease: A Nationwide Swedish Cohort Study.
    Weimers P; Halfvarson J; Sachs MC; Saunders-Pullman R; Ludvigsson JF; Peter I; Burisch J; Olén O
    Inflamm Bowel Dis; 2019 Jan; 25(1):111-123. PubMed ID: 29788069
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Colonic bacterial composition in Parkinson's disease.
    Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
    Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson's Disease: A Systematic Review.
    Boertien JM; Pereira PAB; Aho VTE; Scheperjans F
    J Parkinsons Dis; 2019; 9(s2):S297-S312. PubMed ID: 31498131
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer.
    Hang Z; Lei T; Zeng Z; Cai S; Bi W; Du H
    Biomed Pharmacother; 2022 Jan; 145():112343. PubMed ID: 34864312
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nutritional Risk Factors, Microbiota and Parkinson's Disease: What Is the Current Evidence?
    Boulos C; Yaghi N; El Hayeck R; Heraoui GN; Fakhoury-Sayegh N
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31416163
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intestinal Inflammation and Parkinson's Disease.
    Li Y; Chen Y; Jiang L; Zhang J; Tong X; Chen D; Le W
    Aging Dis; 2021 Dec; 12(8):2052-2068. PubMed ID: 34881085
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease.
    Lopetuso LR; Napoli M; Rizzatti G; Gasbarrini A
    Expert Opin Investig Drugs; 2018 Jun; 27(6):543-551. PubMed ID: 29865875
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gut Vibes in Parkinson's Disease: The Microbiota-Gut-Brain Axis.
    Bullich C; Keshavarzian A; Garssen J; Kraneveld A; Perez-Pardo P
    Mov Disord Clin Pract; 2019 Nov; 6(8):639-651. PubMed ID: 31745471
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models.
    Pellegrini C; Colucci R; Antonioli L; Barocelli E; Ballabeni V; Bernardini N; Blandizzi C; de Jonge WJ; Fornai M
    Neurogastroenterol Motil; 2016 Dec; 28(12):1781-1791. PubMed ID: 27611012
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Primer for Internists.
    Syal G; Kashani A; Shih DQ
    Am J Med; 2018 Sep; 131(9):1017-1024. PubMed ID: 29605414
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enriched Environmental Conditions Modify the Gut Microbiome Composition and Fecal Markers of Inflammation in Parkinson's Disease.
    Singh Y; El-Hadidi M; Admard J; Wassouf Z; Schulze-Hentrich JM; Kohlhofer U; Quintanilla-Martinez L; Huson D; Riess O; Casadei N
    Front Neurosci; 2019; 13():1032. PubMed ID: 31749671
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson's disease.
    Cassani E; Barichella M; Cancello R; Cavanna F; Iorio L; Cereda E; Bolliri C; Zampella Maria P; Bianchi F; Cestaro B; Pezzoli G
    Parkinsonism Relat Disord; 2015 Apr; 21(4):389-93. PubMed ID: 25707302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.